Europe Psoriasis Epidemiology and Patient Flow Analysis - 2018

  • ID: 4516583
  • Report
  • Region: Europe
  • Fore Pharma
1 of 3
The researcher announced the results of its Psoriasis patients study in a new research ‘Europe Psoriasis Epidemiology and Patient Flow Analysis - 2018’. The research provides insights into Psoriasis epidemiology, Psoriasis diagnosed patients, and Psoriasis treatment rate for EU5 countries. The research measures key indicators including prevalence of Psoriasis derived from epidemiological analysis, patients diagnosed with Psoriasis, and patients treated with a drug therapy.

The research study helps executives estimate Psoriasis market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The research provides estimates and forecasts of Psoriasis prevalence, Psoriasis diagnosis rate, and Psoriasis treatment rate for the period 2017 - 2026. The information is presented by EU5 countries including Germany, France, Spain, Italy, and UK.

Key Features of the Report:
  • Psoriasis Patient Flow
  • Psoriasis Prevalence
  • Psoriasis Diagnosed Patients
  • Psoriasis Treated Patients
Note: Product cover images may vary from those shown
2 of 3
1. Psoriasis: Disease Definition
2. Psoriasis Patient Flow in Europe
2A. Psoriasis Prevalence in Europe
2B. Psoriasis Diagnosed Patients in Europe
2C. Psoriasis Treated Patients in Europe
3. Psoriasis Patient Flow in Germany
3A. Psoriasis Prevalence in Germany
3B. Psoriasis Diagnosed Patients in Germany
3C. Psoriasis Treated Patients in Germany
4. Psoriasis Patient Flow in France
4A. Psoriasis Prevalence in France
4B. Psoriasis Diagnosed Patients in France
4C. Psoriasis Treated Patients in France
5. Psoriasis Patient Flow in Spain
5A. Psoriasis Prevalence in Spain
5B. Psoriasis Diagnosed Patients in Spain
5C. Psoriasis Treated Patients in Spain
6. Psoriasis Patient Flow in Italy
6A. Psoriasis Prevalence in Italy
6B. Psoriasis Diagnosed Patients in Italy
6C. Psoriasis Treated Patients in Italy
7. Psoriasis Patient Flow in UK
7A. Psoriasis Prevalence in UK
7B. Psoriasis Diagnosed Patients in UK
7C. Psoriasis Treated Patients in UK
8. Research Methodology

List of Tables
Table 1: Psoriasis Patient Flow in Europe, 2017
Table 2: Psoriasis Patient Flow Forecast in Europe, 2017 - 2026
Table 3: Psoriasis Patient Flow in Germany, 2017
Table 4: Psoriasis Patient Flow Forecast in Germany, 2017 - 2026
Table 5: Psoriasis Patient Flow in France, 2017
Table 6: Psoriasis Patient Flow Forecast in France, 2017 - 2026
Table 7: Psoriasis Patient Flow in Spain, 2017
Table 8: Psoriasis Patient Flow Forecast in Spain, 2017 - 2026
Table 9: Psoriasis Patient Flow in Italy, 2017
Table 10: Psoriasis Patient Flow Forecast in Italy, 2017 - 2026
Table 11: Psoriasis Patient Flow in UK, 2017
Table 12: Psoriasis Patient Flow Forecast in UK, 2017 - 2026

List of Figures
Figures 1: Psoriasis Patient Flow in Europe, 2017
Figure 2: Psoriasis Patient Flow Forecast in Europe, 2017 - 2026
Figure 3: Psoriasis Patient Flow in Germany, 2017
Figure 4: Psoriasis Patient Flow Forecast in Germany, 2017 - 2026
Figure 5: Psoriasis Patient Flow in France, 2017
Figure 6: Psoriasis Patient Flow Forecast in France, 2017 - 2026
Figure 7: Psoriasis Patient Flow in Spain, 2017
Figure 8: Psoriasis Patient Flow Forecast in Spain, 2017 - 2026
Figure 9: Psoriasis Patient Flow in Italy, 2017
Figure 10: Psoriasis Patient Flow Forecast in Italy, 2017 - 2026
Figure 11: Psoriasis Patient Flow in UK, 2017
Figure 12: Psoriasis Patient Flow Forecast in UK, 2017 - 2026
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll